Menu
Enrolling by invitation NCT06885294

Physiotherapy/hypnosis for AVC Patients

No phase Interventional Stroke

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Physiotherapy, Physiotherapy and Hypnosis, Control group Physiotherapy and Hypnosis.
Who it may be relevant to
Registry conditions: Stroke. Basic parameters: 18 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Belgium
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Impact of Physiotherapy Combined to Hypnosis on Superior Limb Functional Capacities of AVC Patients

Overview

Impact of physical therapy with hypnosis on the functional capacity of the upper limb in stroked patients.

Detailed description

The cerebrovascular accident (CVA) is a pathology generating many disabled people. Physiotherapy is one of the usual rehabilitation techniques for a patient with sequelae of ischemia or cerebral hemorrhage. Combined with another therapeutic approach, hypnosis, it could increase the patient's motor performance.

Interventions

  • Behavioral Physiotherapy
    Stroke patients will be randomly assigned to join one of the three groups. The first group will undergo a pre-treatment evaluation, receive 6 sessions of physiotherapy (2 sessions per week, approximately 20-30 minutes each), and undergo a post-treatment evaluation after 1 month. After another month without any treatment, they will undergo a third and final assessment. All evaluations will last approximately 1 hour.
  • Behavioral Physiotherapy and Hypnosis
    Stroke patients will be randomly assigned to join one of the three groups. The second group will undergo a pre-treatment evaluation, receive 6 sessions of physiotherapy combined with hypnosis (2 sessions per week, approximately 20-30 minutes each), and undergo a post-treatment evaluation after 1 month. Patients will continue their standard physiotherapy care during these 4 weeks. After another month without any treatment, they will undergo a third and final assessment. All evaluations will last
  • Behavioral Control group Physiotherapy and Hypnosis
    The control group will be assessed initially and then after 4 weeks. After the second assessment, they will receive 6 sessions of physiotherapy combined with hypnosis (2 sessions per week, approximately 20-30 minutes each), and undergo a post-treatment evaluation after 1 month. All evaluation sessions will last approximately 1 hour.

Primary outcome measures

  • Measurement of joint ranges of motion [Time frame: 8 weeks]
  • assessment of spasticity [Time frame: 8 weeks]
  • functional tests for the upper limb [Time frame: 8 weeks]
  • scales for assessing disability and functional independence [Time frame: 8 weeks]
  • evaluation of muscle strength [Time frame: 8 weeks]
  • Box and Block Test (BBT) [Time frame: 8 weeks]
  • Modified Rankin Scale (mRS) [Time frame: 8 weeks]

Eligibility criteria

Inclusion criteria

  • Adults aged 18 to 80 years old
  • Having experienced a stroke more than 3 months ago
  • Understanding and proficient in the French language
  • Having a functional capacity deficit in at least one of the two upper limbs
  • Being able to independently travel to the Yerne medical center for necessary study appointments.

Exclusion criteria

  • Being under 18 or over 80 years old
  • Having a history of upper limb injuries (fractures, prosthetics, etc.)
  • Having Wernicke's aphasia (language comprehension disorder)
  • Having frontal lobe syndrome
  • Undergoing chemotherapy
  • Having respiratory disorders (respiratory failure of more than 70%) or receiving oxygen therapy
  • Having epilepsy
  • Having dementia
  • Having untreated hearing impairments
  • Being diagnosed with schizophrenia or paranoïa
  • Experiencing significant concentration difficulties

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Supportive care

Study locations

Belgium · 1 center
  • GIGA Science and Perception Research Group CHU Liège — Liège

Identifiers

NCT: NCT06885294 · 2022-306

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗